Genotype-guided Warfarin Individualized Treatment

NACompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

January 16, 2017

Study Completion Date

May 1, 2017

Conditions
Atrial FibrillationDeep Venous Thrombosis
Interventions
BEHAVIORAL

Genotype-guided dosing algorithm for warfarin

Intervention:initial dosing of warfarin for the first 3 days of treatment will be determined by IWPC( International Warfarin Pharmacogenetics Consortium) algorithm (PG-1),a second dose adjustment will be made after 3 doses of warfarin using a dose revision algorithm (PG-2) that combined INR values,the dose will be adjusted depending on the measurements of INR values after 7 days.The overall follow-up period is 12 weeks.

BEHAVIORAL

Standard initiation dose for warfarin

Intervention:initial dosing of warfarin for the first 3 days of treatment will be determined by standard initiation dose. Following this initiation dose of warfarin,the dose will be adjusted depending on the measurements of INR values after 3 days.The overall follow-up period is 12 weeks.

Trial Locations (15)

410002

The People's Hospital of Hunan Province, Changsha

410004

The Central Hospital of Changsha, Changsha

410006

The Fourth Hospital of Changsha, Changsha

410013

The Third Xiangya Hospital of Central South University, Changsha

411100

The Central Hospital of Xiangtan, Xiangtan

411101

The First People's Hospital of Xiangtan, Xiangtan

413000

The Central Hospital of Yiyang, Yiyang

417000

The Central Hospital of Loudi, Loudi

422000

The Central Hospital of Shaoyang, Shaoyang

422001

The First People's Hospital of Shaoyang, Shaoyang

423000

The First People's Hospital of Chenzhou, Chenzhou

Unknown

The Third Hospital of Changsha, Changsha

The Xiangya Hospital of Central South University, Changsha

The First Affiliated Hospital of Nanhua university, Hengyang

The Second Affiliated Hospital of Nanhua university, Hengyang

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER

NCT02211326 - Genotype-guided Warfarin Individualized Treatment | Biotech Hunter | Biotech Hunter